Allurion Technologies (ALURD) Cash from Investing Activities (2022 - 2024)
Allurion Technologies' (ALURD) quarterly Cash from Investing Activities came in at -$72000.0 in Q3 2024, up 91.0% YoY from -$37696.3 in Q4 2023, and up 83.45% on a QoQ basis from -$435000.0 in Q2 2024.
Allurion Technologies (ALURD) Cash from Investing Activities (2022 - 2024) Analysis & Trends
Allurion Technologies (ALURD) has 3 years of Cash from Investing Activities data on file, last reported at -$72000.0 in Q3 2024.
- Quarterly Cash from Investing Activities rose 91.0% year-over-year to -$72000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2024 was -$611000.0 (up 61.96% YoY) and the FY2024 annual result came in at -$611000.0, up 61.96% from the prior year.
- Cash from Investing Activities climbed to -$72000.0 in Q3 2024, from -$435000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $157000.0 in Q3 2022 to a low of -$800000.0 in Q3 2023.
- A 3-year average of -$279888.9 and a median of -$277000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities plunged 609.55% — and 2024, when it surged 91.0%.
- Tracing ALURD's Cash from Investing Activities over 3 years: stood at -$459000.0 in 2022, then increased by 13.29% to -$398000.0 in 2023, then jumped by 81.91% to -$72000.0 in 2024.
- The last three Cash from Investing Activities figures came in at -$72000.0 (Q3 2024), -$435000.0 (Q2 2024), and -$104000.0 (Q1 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -72,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -435,000.00 |
| Jun 30, 2024 | -435,000.00 |
| Mar 31, 2024 | -104,000.00 |
| Mar 31, 2024 | -104,000.00 |
| Dec 31, 2023 | -398,000.00 |
| Dec 31, 2023 | -398,000.00 |
| Sep 30, 2023 | -800,000.00 |
| Sep 30, 2023 | -800,000.00 |
| Jun 30, 2023 | -131,000.00 |
| Jun 30, 2023 | -131,000.00 |
| Mar 31, 2023 | -277,000.00 |
| Mar 31, 2023 | -277,000.00 |
| Dec 31, 2022 | -459,000.00 |
| Dec 31, 2022 | -459,000.00 |
| Sep 30, 2022 | 157,000.00 |
| Sep 30, 2022 | 157,000.00 |